» Articles » PMID: 20156265

Partially Erupted Third Molars As a Potential Source of Infection in Patients Receiving Peripheral Stem Cell Transplantation for Malignant Diseases: a Retrospective Study

Overview
Journal Eur J Oral Sci
Specialty Dentistry
Date 2010 Feb 17
PMID 20156265
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Forty-four patients with malignant diseases for which they received peripheral stem cell transplant therapy (PSCT) were retrospectively studied regarding local and systemic infection originating from around partially erupted third molars (PEMs). Twenty-two patients had one or more PEMs, while 22 patients had none. Data were retrieved from medical and dental records. Systemic and local signs of infection and treatment were assessed. We recorded the number of transplanted CD34(+) blood stem cells, days with white blood cell counts < 0.5 x 10(9) l(-1), days until engraftment, maximum level of C-reactive protein (CRP), days with fever, positive blood cultures, days taking antibiotics, days drinking < 0.5 l, days of total parenteral nutrition, days receiving intravenously administered analgesics, and number of admission days. No statistically significant difference was detected between patients with PEMs and those without PEMs regarding any of the studied parameters. Of patients with PEMs, 36% (8 of 22) developed local infections around PEMs during the PSCT period. The study indicates that PEMs pose no significant risk of causing systemic infection in patients receiving PSCT for malignant diseases but increase the risk of developing a local infection, justifying close supervision and early treatment in cases of local infection during PSCT treatment.

Citing Articles

Dental evaluation and clearance prior to allogeneic hematopoietic cell transplantation.

Dean D, Lee S, Cutler C, Gooley T, Hujoel P, Oh U Oral Dis. 2023; 30(4):2635-2644.

PMID: 37650229 PMC: 10902180. DOI: 10.1111/odi.14717.


Brazilian dental consensus on dental management in hematopoietic stem cell transplantation - Part I - pre-HSCT.

Correa M, Granzotto F, Innocentini L, Reis T, de Lima E, Varanda R Hematol Transfus Cell Ther. 2023; 45(3):358-367.

PMID: 37295969 PMC: 10499583. DOI: 10.1016/j.htct.2023.04.001.


Dental status and risk of odontogenic complication in patients undergoing hematopoietic stem cell transplant.

Hansen H, Estilo C, Owosho A, Solano A, Randazzo J, Huryn J Support Care Cancer. 2020; 29(4):2231-2238.

PMID: 32901321 PMC: 8432266. DOI: 10.1007/s00520-020-05733-1.


Apical periodontitis as potential source of infection in patients with lymphoma treated with chemotherapy.

Skallsjo K, Johansson J, Jonasson P, Hasseus B Clin Oral Investig. 2019; 24(1):133-140.

PMID: 31041576 DOI: 10.1007/s00784-019-02909-w.


Dental status does not predict infection during stem cell transplantation: a single-center survey.

Guenther A, Losch E, Schiessl M, Schrauder A, Humpe A, Repp R Bone Marrow Transplant. 2017; 52(7):1041-1043.

PMID: 28481351 DOI: 10.1038/bmt.2017.76.